{
  "report_rows": [
    {
      "kpi": "Adjusted operating EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.84 vs. cons $2.811",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Brokerage organic growth",
      "prediction": "BEAT",
      "answer": "pred ~5.0% vs. cons 4.89%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDAC",
      "prediction": "BEAT",
      "answer": "pred ~$1.280B vs. cons $1.267B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Brokerage organic growth (Q3'26)",
      "prediction": "LOWER",
      "answer": "guide ~5.5% vs. cons 5.66%",
      "confidence": "LOW"
    },
    {
      "kpi": "Brokerage organic growth (FY'26)",
      "prediction": "BETTER",
      "answer": "guide ~5.5% vs. cons 4.99%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AssuredPartners synergies (early 2028)",
      "prediction": "UNCHANGED",
      "answer": "guide up to ~$325M vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 high setup and near-term guide risk",
  "day5_confidence": "MEDIUM"
}